Transdermal Nicotine Patch 21mg/Day
Natural health product licensed in Canada
- Licence holder
- Dr. Reddy's Laboratories Canada Inc.
- NPN or DIN-HM
- 02241228
- Status
- Active licence
- Licence date
- 3 December 2007
- Revision date
- 7 May 2025
- Form
- Timbre transdermique
- Route of administration
- Transdermique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Capric triglycéride, Acrylate vinylacetate copolymères, Aluminum, Metharylic acid esters copolymer, Paper
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 patch | Not specified |
Uses authorised in Canada
Transdermal nicotine patch is indicated as a temporary aid used to facilitate smoking cessation in smokers who strongly desire to give up their smoking habit.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 02241228
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.